eTMF Structure, Setup, and Implementation Case Study

Post on 12-Jan-2015

2,166 views 1 download

Tags:

description

This presentation describes a case study of an eTMF structure, setup, and implementation at a biotechnology company currently conducting a pivotal Phase 3 clinical study in 70 centers worldwide.

transcript

A Case Study of an eTMF Implementationat a Small Biotech

Adair Turner, MSc, RACRegulatory Affairs ManagerMission3, Inc.

The views and opinions expressed in the following PowerPoint slides are those of the individual presenter and should not be attributed to Drug Information Association, Inc. (“DIA”), its directors, officers, employees, volunteers, members, chapters, councils, Special Interest Area Communities or affiliates, or any organization with which the presenter is employed or affiliated.

 

These PowerPoint slides are the intellectual property of the individual presenter and are protected under the copyright laws of the United States of America and other countries. Used by permission. All rights reserved. Drug Information Association, DIA and DIA logo are registered trademarks or trademarks of Drug Information Association Inc. All other trademarks are the property of their respective owners.

Disclaimer

2www.diahome.orgDrug Information Association

• This session provides a case study of an eTMF implementation at a biotechnology company currently conducting a pivotal Phase 3 clinical study in 70 centers worldwide.

• We will discuss our experience, process management, and lessons learned.

Agenda

Drug Information Association www.diahome.org 3

• Not enough resources!• The logistics of managing

paper-based processes with limited resources was challenging, overwhelming, and time consuming.

• Documentation was inconsistent, incomplete, missing, expired, and/or redundant.

Problem

Drug Information Association www.diahome.org 4

“Welcome aboard, Bob. Your job is to figure out what the heck happened here.”

• Prepare for an upcoming NDA eCTD submission and the subsequent GCP inspection.

• Transform existing paper based processes with a centralized electronic solution that would maximize resources by using a globally available cloud-based framework.

Objective

Drug Information Association www.diahome.org 5

• DIA TMF Reference Model utilization– Clearly structured to account for documentation levels

and the trial complexity (global, country, site)– The TMF RM is intended to provide a collaborative

advantage to stakeholders in creating and managing their TMFs.

Partner’s System Requirements

Drug Information Association www.diahome.org 6

• Software as a Service delivery model in which software and associated data are centrally hosted in the cloud and available globally

• Low cost and commitment• Quickly and easily implemented• Document management capabilities

– Check in/check out, version control, audit trail, work flows and lifecycles, etc.

– Ability to use the same system for multiple projects

• Flexible• Minimal validation required

Additional Requirements

Drug Information Association www.diahome.org 7

Program Plan - 5 Projects

Drug Information Association www.diahome.org 8

1. eTMF Structure, Setup, and Implementation

2. Ongoing Clinical Trial Document Processing

3. Legacy Clinical Trial Data Processing

4. EDM Regulatory Structure, Setup, and Implementation

5. NDA Project Planning and eCTD Document Processing

eTMF Solution

Drug Information Association www.diahome.org 9

Together, we developed a flexible process:

Process Definition

Drug Information Association www.diahome.org 10

Technology Setup – 5 months

Drug Information Associationwww.diahome.org

11

The Process - Partner

Drug Information Association www.diahome.org 12

• CRA receives paper document(s) at site, identifies/verifies content, completes online transmittal form, assembles document package, and ships document package to Scanning Vendor

Scanning Vendor Process

Drug Information Association www.diahome.org 13

eTMF Vendor Process

Drug Information Association www.diahome.org 14

eTMF Vendor QC Checklist

Drug Information Association www.diahome.org 15

Verify:

•Page count

•Naming convention

•Metadata

•Location

• Partner audited both the Scanning Vendor and the eTMF Vendor to ensure appropriate quality documentation prior to signing.

• SOPs/Methodologies/Working Practices for Scanning vendor, eTMF vendor, and Partner company that cover each part of the process

• Appropriate and documented training• Validation documentation

Documentation

Drug Information Association www.diahome.org 16

• Partner went through the DIA TMF RM and added the naming convention they wanted for each item.

Document Naming Convention

Drug Information Association www.diahome.org 17

• Beyond the metadata suggested by the DIA TMF RM, we added a field for the unique “Physical Document Locator” that corresponds to the hard copy and wet signature if needed.

Metadata

Drug Information Association www.diahome.org 18

Current Study

Drug Information Association www.diahome.org 19

• We used the current Ph. 3 study as our initial project and pilot.

• Together, we wrote, reviewed, and implemented Scanning Methodology and Work Practice documents.

• Scanned, indexed, and filed approximately 3500 documents in 6 months.

• Implemented EDMS for Regulatory documents during this timeframe as well.

• More than 60,000 legacy documents were shipped to scanning vendor (in 80 boxes).

• The shipment included a MS Excel spreadsheet that listed the documents that were in the boxes and was organized by section of a previous Trial Master File and by folder identifier.

• A new methodology document was written for scanning the legacy documents.

Legacy Process

Drug Information Association www.diahome.org 20

• The Scanning Vendor had to do a great deal of document reconciliation in order to index and scan the documents and timelines were pushed back by a couple of months.

• Legacy Study #1 contains approximately 26,500 documents and must be complete in 2 months!

• In order to meet timelines, documents must be reviewed and filed in under 1 min each.

• A weekly status report is provided to our partner showing the status of planned completion vs. actual completion.

Legacy Study

Drug Information Association www.diahome.org 21

• Scanning vendor indexed documents with metadata provided on the Excel spreadsheet.

• Text file indexes are uploaded with the PDF documents to a secure SFTP site.

• The text file is used to populate the document metadata as the documents are automatically loaded into a “Staging Area.”

Automated Metadata

Drug Information Association www.diahome.org 22

Legacy Document Transfer

Drug Information Association www.diahome.org 23

• All study records are globally accessible, available and organized. Partner is able to easily identify gaps and assess completeness.

• New processes, standards and controls ensure increased TMF quality.

• Time associated with file requests, audits, and inspections have decreased. While the cost of mailing documents, searching for information and reproducing redundant documentation is significantly lowered.

How is it better?

Drug Information Association 24

• Establish paper document classification.

• Identify document naming conventions and metadata early.

• Correspondence should be relevant and organized.

• Planning and communication are the keys to estimating and managing program timelines.

Lessons Learned

Drug Information Association www.diahome.org 25

Drug Information Association www.diahome.org 26

Let me know if you have any questions!

aturner@mission3.com